1. Healthcare Procurement Favors Scale, Not Quality

Healthcare projects are typically commissioned through risk‑averse procurement models:

• RFQs/RFPs prioritize:
• • Number of completed hospitals
  • Total firm revenue
  • Bonding capacity
  • Geographic footprint
• Selection committees often equate size with safety

This creates a feedback loop:

“We hired them before, so we’ll hire them again.”

Even when a small firm has deep healthcare expertise, they may be filtered out before design quality, research literacy, or patient‑centered thinking are even evaluated.

Result:
Small firms are excluded at the gate—not at the table.

2. Healthcare Equates Resources with Risk Mitigation

Healthcare systems operate under:

• Thin margins
• Regulatory pressure
• Legal exposure
• Public accountability

As a result, decision‑makers often assume:

• Large firms = more staff = fewer delays
• Big brand = fewer lawsuits
• Global presence = stronger QA/QC

This is often perceived safety, not proven performance.

Ironically:

• Large firms frequently staff projects with junior teams
• Small firms often provide senior‑level attention throughout

Result:
Risk is managed symbolically, not empirically.

3. Evidence‑Based Design Is Mistaken for Firm Size

Healthcare leaders frequently say they want:

• Evidence‑based design
• Research‑driven outcomes
• Innovation in patient care

But in practice, EBD is often reduced to:

• Checklists
• Buzzwords
• Marketing claims

Large firms:

• Can afford internal research departments
• Publish white papers and glossy reports
• Speak the language of administrators fluently

Small firms:

• Often practice EBD more rigorously
• But lack the resources to package it as institutional credibility

Result:
Research literacy is confused with research branding.

4. Healthcare Culture Is Deeply Conservative

Despite being science‑driven, healthcare organizational culture is conservative:

• Innovation is welcomed after it’s proven elsewhere
• Familiarity outweighs originality
• “Different” is often equated with “risky”

Small firms are more likely to:

• Question outdated planning models
• Propose human‑centered alternatives
• Challenge institutional norms

But this can trigger resistance:

“That’s not how hospitals work.”

Result:
Transformative ideas are sidelined in favor of incremental repetition.

5. Fee Structures Penalize Small Firms

Healthcare projects demand:

• Extensive documentation
• Long timelines
• Heavy coordination
• Pro bono pre‑design effort

Large firms absorb this through volume.
Small firms often:

• Carry disproportionate financial risk
• Are asked to “prove themselves” more
• Are underpaid relative to liability

This leads to a perception that:

“If they were better, they’d be bigger.”

Which ignores the economic reality of the sector.

6. Marketing Visibility ≠ Design Impact

Large healthcare firms dominate:

• Conference panels
• Industry awards
• Trade publications
• Advisory boards

Small firms often:

• Focus on doing the work, not promoting it
• Don’t have PR teams or award budgets
• Build reputations quietly through outcomes

Healthcare decision‑makers are busy and exposed primarily to what’s visible, not what’s effective.

Result:
Visibility becomes a proxy for value.

7. Small Firms Threaten Established Power Structures

Healthcare architecture is intertwined with:

• Construction firms
• Consultants
• Facility standards groups
• Vendor ecosystems

Small firms are more likely to:

• Question vendor‑driven layouts
• Push back on inefficient standards
• Advocate for patient experience over operations

This can be uncomfortable for entrenched systems.

Result:
Underrating becomes a form of institutional self‑protection.

The Irony: What Healthcare Actually Needs

Many of healthcare’s biggest challenges—burnout, patient dissatisfaction, inequity, rising costs—are human problems, not scale problems.

Small to medium firms often excel at:

• Deep listening
• Clinician collaboration
• Patient‑centered thinking
• Context‑specific solutions
• Design accountability

These are precisely the qualities evidence‑based healthcare design research supports—yet the industry structure rewards the opposite.

Bottom Line

Small and mid‑sized firms are underrated in healthcare because:

• Procurement rewards familiarity over performance
• Risk is judged by brand, not outcomes
• Research is confused with marketing
• Innovation is culturally discouraged
• Economic models favor scale
• Visibility outweighs substance

Not because they are less capable.

Below are concrete, well‑documented cases where small or mid‑sized architectural firms outperformed large firms (or large‑firm norms) in healthcare projects, measured by patient outcomes, operational success, user satisfaction, and long‑term impact—not marketing visibility. Each example is explicitly tied to evidence‑based performance, with sources cited.

1. Maggie’s Cancer Care Centres (UK)

Small / mission‑driven design teams vs. conventional NHS hospital architecture

Firm profile

• Each Maggie’s Centre is designed by a small or mid‑sized studio (often fewer than 50 staff at the time of commission)
• Operates outside large healthcare‑corporate design pipelines

Project impact

• Maggie’s Centres consistently outperform adjacent NHS facilities in:
• • Patient emotional well‑being
  • Stress reduction
  • Social support engagement
  • Perceived dignity and control
    [architizer.com], [archdaily.com]

Why this matters

Traditional NHS hospitals—many designed by large multidisciplinary firms—optimize for:

• Throughput
• Standardization
• Risk containment

Maggie’s Centres prioritize:

• Domestic scale
• Nature immersion
• Psychological safety
• Choice and autonomy

Independent research using DuBose & Ulrich healing‑space frameworks confirms Maggie’s Centres align more closely with evidence‑based healing variables than typical hospital outpatient environments.
[interiored...tors.co.uk], [re-thinkin...future.com]

Key takeaway:
Small firms succeeded by rejecting institutional templates—not by scaling them.

2. Butaro District Hospital, Rwanda

MASS Design Group (then <30 staff) vs. global healthcare norms

Firm profile

• MASS Design Group was a small, research‑driven nonprofit practice when commissioned
• No global healthcare portfolio at the time

Design outcomes

• Natural cross‑ventilation eliminated need for mechanical HVAC
• Infection control achieved through spatial planning, not technology
• Significantly reduced airborne disease transmission (TB in particular)

Performance results

• Lower hospital‑acquired infection rates
• Improved staff safety
• Lower operational costs than comparable mechanically ventilated hospitals

This project is repeatedly cited in global health design research as outperforming Western, large‑firm hospital models in low‑resource contexts.
[healthdesign.org]

Why large firms underperformed here

• Relied on high‑energy mechanical systems
• Imported inappropriate typologies
• Designed for capital‑rich contexts, not clinical reality

Key takeaway:
Small firms outperformed by designing from first principles and evidence, not precedent.

3. Paimio Sanatorium (Finland )

Alvar Aalto’s small studio vs. institutional modernism

Firm profile

• Aalto’s office was small and experimental
• No hospital portfolio at scale

Evidence‑based innovations

• Patient rooms oriented for sunlight
• Color psychology applied to ceilings and walls
• Noise‑reducing fixtures
• Furniture designed for breathing comfort

Many of these strategies were later validated by Ulrich and modern EBD research, decades after construction.
[healthdesign.org]

Large institutional firms at the time focused on:

• Monumentality
• Efficiency
• Visual modernism

Aalto focused on:

• Patient perception
• Sensory experience
• Recovery physiology

Key takeaway:
Healthcare innovation historically comes from small practices, then gets absorbed by large ones later.

4. Single‑Room ICU Units Designed by Specialty Firms

Specialist healthcare boutiques vs. large A/E conglomerates

Evidence context

A 2024 meta‑analysis of 12 studies (12,719 patients) shows:

• Single‑patient rooms reduce nosocomial infections by ~32%
• Lower MDRO acquisition
• Reduced bacteremia rates
  [frontiersin.org]

Where small firms outperform

Boutique healthcare firms:

• Advocate for single‑room layouts early
• Design visibility, acoustics, and staff workflows carefully
• Balance infection control with monitoring

Large firms:

• Often default to mixed or semi‑private rooms due to:
• • Cost models
  • Developer pressure
  • Legacy standards

Post‑occupancy evaluations show hospitals that fully committed to single‑room strategies (often with smaller design teams) achieved measurable infection reductions, while many large‑firm projects diluted the concept.
[jamanetwork.com]

Key takeaway:
Small firms win by holding the line on evidence when others compromise.

5. Acoustic Retrofits and ICU Noise Reduction

Targeted small‑team interventions vs. original large‑firm designs

Case: Fiona Stanley Hospital ICU (Australia)

• Original hospital: large, multinational design team
• Noise levels exceeded WHO guidelines
• Patient sleep disruption documented

Retrofit intervention

• Led by a small, interdisciplinary design‑research team
• Acoustic modeling
• Targeted material changes
• Workflow adjustments

Results

• Significant noise reduction
• Improved patient sleep
• Reduced staff fatigue
  [journals.sagepub.com]

Why this matters The original large‑firm design met codes, but failed performance. The small‑team intervention corrected it using evidence.

Key takeaway:
Compliance ≠ healing performance.

Pattern Across All Examples

Small and mid‑sized firms outperform large firms in healthcare when success is measured by:

Metric: Small Firms vs. Large Firms

Patient experience

✅ High

⚠️ Variable

Evidence fidelity

✅ Strong

⚠️ Selective

Innovation

✅ First‑mover

❌ Risk‑averse

Post‑occupancy results

✅ Measured

❌ Rarely revisited

Human‑centered design

✅ Core value

⚠️ Secondary

[healthdesign.org]

The Real Conclusion (Uncomfortable but Accurate)

Small firms don’t outperform despite their size.
They outperform because of it:

• Shorter decision chains
• Senior designers engaged throughout
• Willingness to challenge norms
• Closer clinician and patient collaboration
• Less dependence on legacy standards

Healthcare underrates them because procurement rewards predictability, not performance.